Skip to search formSkip to main contentSkip to account menu

Daflon 500

Known as: D500 
Daflon 500 is a phlebotonic drug and a vascular protecting agent. It is reported to improve microcirculation in chronic venous insufficiency by… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Diosmin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Daflon 500 mg and Venous Leg Ulcer: New Results From a Meta-Analysis
The objective of this study was to assess the effect of oral treatment with Daflon 500 mg (micronized purified flavonoid fraction… 
Review
1995
Review
1995
Intravital capillaroscopy in patients with chronic venous insufficiency and lymphoedema: relevance to Daflon 500 mg.
Microangiopathy of chronic venous insufficiency is characterized by elongated, dilated and coiled skin capillaries, which are… 
1995
1995
Evaluation by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Daflon 500 mg) in the treatment of upper limb lymphedema.
Upper limb lymphedema after conventional treatment of breast cancer occurs in about 20% of all treated cases, even after… 
1994
1994
Pharmacologic properties of Daflon 500 mg.
AIMS AND METHODS Some pharmacologic activities of a micronized flavonoid complex consisting of 90% diosmin + 10% hesperidin… 
1994
1994
Transcutaneous Oxygen Tension Measurement in Patients with Chronic Arterial Obstructive Disease: Reliability and Long-Term variability of the Method
Although transcutaneous oxygen tension (TcpO2) measurement may be useful for assessing changes in regional perfusion induced over… 
1994
1994
Control of Lymphatic Pumping: Interest of Daflon 500 mg
Objective: To determine the effects of Daflon 500 mg on lymph flow, known to be modulated by lymph formation and contractility of… 
1994
1994
Concurrent Balloon Dilation in a Patient with Mitral Stenosis and Coronary Artery Disease
A patient with coexistent mitral stenosis and coronary artery disease is described in whom a concurrent balloon dilation was… 
1993
1993
Antioxidant activity of micronized diosmin on oxygen species from stimulated human neutrophils.
1989
1989
Lymphagogue and pulsatile activities of Daflon 500 mg on canine thoracic lymph duct.
An earlier report proved that Daflon 500 mg constituted of 90% diosmin and 10% hesperidin exerts a lymphagogue effect on dogs… 
1989
1989
A long term treatment with a venotropic drug. Results on efficacy and safety of Daflon 500 mg in chronic venous insufficiency.
UNLABELLED Drugs for long term administration have to prove their efficacy and safety. Previously published double blind… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)